Literature DB >> 210254

Experimental respiratory syncytial virus pneumonia in cebus monkeys.

L S Richardson, R B Belshe, D L Sly, W T London, D A Prevar, E Camargo, R M Chanock.   

Abstract

Into 14 juvenile cebus monkeys that lacked serum antibodies for RS virus 10(8) plaque-forming units (pfu) of wild-type respiratory syncytial (RS) virus were inoculated transtracheally. Roentgenographic evidence of pneumonia developed in 13 of 14 infected animals. Gross pathologic changes occurred in each of the 13 monkeys that were sacrificed. Patchy areas of red consolidation were seen in the lower lobes 24 hours after inoculation, and there was progression to gray consolidation seven days later. Each of the infected animals had histologic evidence of interstitial pneumonia. Changes were detected in the lung as early as 24 hours after inoculation; they consisted primarily of infiltration of the alveolar wall. By the fourth to sixth day after inoculation there was marked interstitial thickening, pulmonary consolidation, formation of multinucleated giant cells and development of eosinophilic cytoplasmic inclusion bodies within alveolar cells. RS viral antigens, detected by indirect immunofluorescence, were distributed throughout cells of the alveolar wall and the bronchiolar epithelium. The virus grew to highest titer in the lungs on the fourth to sixth day after inoculation; up to 10(8) pfu/gram of tissue were detected. The cebus monkey represents the first experimental host to develop extensive pulmonary lesions during infection with respiratory syncytial virus.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 210254     DOI: 10.1002/jmv.1890020108

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  16 in total

1.  Respiratory syncytial virus infection in inbred mice.

Authors:  G A Prince; R L Horswood; J Berndt; S C Suffin; R M Chanock
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

Review 2.  Respiratory syncytial virus. Brief review.

Authors:  E J Stott; G Taylor
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

3.  Infant baboons infected with respiratory syncytial virus develop clinical and pathological changes that parallel those of human infants.

Authors:  James F Papin; Roman F Wolf; Stanley D Kosanke; Justin D Jenkins; Sara N Moore; Michael P Anderson; Robert C Welliver
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-02-15       Impact factor: 5.464

Review 4.  Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment.

Authors:  J B Domachowske; H F Rosenberg
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

5.  Efficacy of RD3-0028 aerosol treatment against respiratory syncytial virus infection in immunosuppressed mice.

Authors:  K Sudo; W Watanabe; K Konno; R Sato; T Kajiyashiki; S Shigeta; T Yokota
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

6.  Respiratory syncytial virus infection in owl monkeys: viral shedding, immunological response, and associated illness caused by wild-type virus and two temperature-sensitive mutants.

Authors:  G A Prince; S C Suffin; D A Prevar; E Camargo; D L Sly; W T London; R M Chanock
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

7.  In vivo inhibition of respiratory syncytial virus by ribavirin.

Authors:  J F Hruska; P E Morrow; S C Suffin; R G Douglas
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

Review 8.  Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma.

Authors:  Shyam S Mohapatra; Sandhya Boyapalle
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

9.  Respiratory syncytial virus infection in mice.

Authors:  G Taylor; E J Stott; M Hughes; A P Collins
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

10.  Cell-mediated immune response to respiratory syncytial virus infection in owl monkeys.

Authors:  W C Koff; F R Caplan; S Case; S B Halstead
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.